UROGEN PHARMA LTD (URGN:NASDAQ)
$40 0.2 (0.5025%)
Analysed UROGEN PHARMA LTD (URGN:NASDAQ) News Sources
UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution
02-06-2026
yahoo.com
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05-06-2026
yahoo.com
Will UroGen’s Jelmyto Generic Deal with Teva Redefine UroGen Pharma's (URGN) Narrative?
08-06-2026
yahoo.com
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
14-06-2026
fool.com
Non-muscle Invasive Bladder Cancer Market Dynamics to Shift During the Forecast Period (2026-2036) as Novel Targeted and Gene Therapies Enter Late-Stage Development | DelveInsight
23-06-2026
yahoo.com
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares?
01-07-2026
fool.com
Urogen Pharma (URGN) is a Great Momentum Stock: Should You Buy?
07-07-2026
yahoo.com
UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
08-07-2026
yahoo.com
UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run
12-07-2026
fool.com
UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103
15-07-2026
yahoo.com
What is the current price of UROGEN PHARMA LTD (URGN:NASDAQ)?
The current price of UROGEN PHARMA LTD (URGN:NASDAQ) is $40.
UROGEN PHARMA LTD (URGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of UROGEN PHARMA LTD (URGN:NASDAQ) since the previous trading day is $0.2.
UROGEN PHARMA LTD (URGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of UROGEN PHARMA LTD (URGN:NASDAQ) since the previous trading day is 0.5025%.
What is the most recent average sentiment score for UROGEN PHARMA LTD (URGN:NASDAQ)?
The most recent average sentiment score for UROGEN PHARMA LTD (URGN:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for UROGEN PHARMA LTD (URGN:NASDAQ)?
The most recent sentiment for UROGEN PHARMA LTD (URGN:NASDAQ) is .
SEC-8K** Filing Available For UROGEN PHARMA LTD (URGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.